Status:

TERMINATED

Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders

Lead Sponsor:

Johns Hopkins University

Conditions:

Gastroparesis

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Gastrointestinal (GI) dysmotility is common in GI motility disorders, such as functional dyspepsia (FD) gastroparesis and chronic constipation. The symptoms of GI dysmotility include abdominal discomf...

Eligibility Criteria

Inclusion

  • Inclusion criteria for FD patients
  • Bothersome postprandial fullness
  • Symptoms of early satiation, epigastric pain, epigastric burning during the last 3 months
  • No evidence of structural disease including at upper endoscopy that is likely to explain the symptoms.
  • Males and females between ages 18-80 yrs;
  • Subjects with high probability for compliance and completion of the study.
  • Inclusion criteria for chronic constipation patients
  • Satisfying Rome IV criteria for diagnosis of functional constipation;
  • abdominal X-ray or anorectal manometry test during the past 3 months indicating delayed colonic transit (more than 20% ingested markers are retained) or abnormal colonic motility;
  • ages 18-80 years;
  • no constipation medication for a minimum of 1 week before enrollment except for rescue agents (stimulant laxatives, such as bisacodyl);
  • willing to comply with the treatment regimen.
  • Inclusion criteria for gastroparesis patients
  • At least one severe gastroparetic symptom or two moderate gastroparetic symptoms (see assessment of gastroparetic symptoms);
  • Abnormal gastric emptying diagnosed during the past year;
  • Males and females between ages 18-80 yrs;
  • Subjects with high probability for compliance and completion of the study.
  • Upper endoscopy or upper GI within last 2 years showing no evidence of gastric bezoar, stricture, or peptic ulcer.
  • Exclusion criteria:
  • History of gastric bezoar or diverticulitis.
  • Severe daily abdominal pain requiring narcotic medications.
  • Previous gastro-esophageal surgery including vagotomy, fundoplication, gastric bypass, ulcer surgery.
  • Prior GI surgery except for uncomplicated appendectomy and laparoscopic cholecystectomy;
  • Surgery within the past 3 months.
  • Female of childbearing age who is not practicing birth control and/or is pregnant or lactating. (Confirm with urine pregnancy test).
  • Those who have been treated with acupuncture or those who are familiar with acupuncture points.
  • Anyone with an implantable cardiac pacemaker or defibrillator.
  • unable to give informed consent;
  • taking prokinetics, anticholinergic or dopaminergic agents;
  • history of gastrointestinal surgery;
  • pregnant or preparing to conceive a child;
  • diabetes;
  • allergic to skin preparation.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 29 2022

    Estimated Enrollment :

    27 Patients enrolled

    Trial Details

    Trial ID

    NCT04349891

    Start Date

    October 1 2020

    End Date

    July 29 2022

    Last Update

    September 19 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, United States, 21224